Inhalable Tobramycin Excipient Enhanced Growth Dry Powder Aerosol in Pseudomonas aeruginosa Induced Lung Infection

S Poudel; Rudra Pangeni; Mohammad A M Momin; A Hassan; DR Farkas; CJ Dalton; Jason D Kang; P Hylemon; P Longest; M Hindle; Q Xu

Inhalable Tobramycin Excipient Enhanced Growth Dry Powder Aerosol in Pseudomonas aeruginosa Induced Lung Infection

S Poudel
, Rudra Pangeni
, Mohammad A M Momin
, A Hassan
, DR Farkas
, CJ Dalton
, Jason D Kang
, P Hylemon
, P Longest
, M Hindle
, Q Xu

Department of Pharmaceutical Sciences

Research output: Contribution to conference › Presentation

Original language	American English
State	Published - 2024
Event	Virginia Drug Discovery Consortium 2024 - Virginia Beach, United States Duration: May 30 2024 → May 31 2024

Conference

Conference	Virginia Drug Discovery Consortium 2024
Country/Territory	United States
City	Virginia Beach
Period	5/30/24 → 5/31/24

Cite this

@conference{cb96825156a7499395b6f8422dec1d31,

title = "Inhalable Tobramycin Excipient Enhanced Growth Dry Powder Aerosol in Pseudomonas aeruginosa Induced Lung Infection",

author = "S Poudel and Rudra Pangeni and Momin, \{Mohammad A M\} and A Hassan and DR Farkas and CJ Dalton and Kang, \{Jason D\} and P Hylemon and P Longest and M Hindle and Q Xu",

year = "2024",

language = "American English",

note = "Virginia Drug Discovery Consortium 2024 ; Conference date: 30-05-2024 Through 31-05-2024",

}

TY - CONF

T1 - Inhalable Tobramycin Excipient Enhanced Growth Dry Powder Aerosol in Pseudomonas aeruginosa Induced Lung Infection

AU - Poudel, S

AU - Pangeni, Rudra

AU - Momin, Mohammad A M

AU - Hassan, A

AU - Farkas, DR

AU - Dalton, CJ

AU - Kang, Jason D

AU - Hylemon, P

AU - Longest, P

AU - Hindle, M

AU - Xu, Q

PY - 2024

Y1 - 2024

M3 - Presentation

T2 - Virginia Drug Discovery Consortium 2024

Y2 - 30 May 2024 through 31 May 2024

ER -